Aomori

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Multiple myeloma3 trials
• Head and neck cancer1 trial

Phase

• Phase 33 trials
• Phase 1/21 trial

Status

• Active, not recruiting2 trials
• Recruiting2 trials

Lead sponsor

• GlaxoSmithKline4 trials

Running trials

• Recruiting

  A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma

  NCT06256588· Phase 3· GlaxoSmithKline· Source

  Contact: Takashi Kasai (principal investigator)

• Recruiting

  A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments

  NCT05714839· Phase 1/2· GlaxoSmithKline· Source

  Contact: Tomoaki Akagi (principal investigator)

• Active, not recruiting

  Japan Expansion Cohort: Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

  NCT06868667· Phase 3· GlaxoSmithKline· Source

• Active, not recruiting

  Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

  NCT04246047· Phase 3· GlaxoSmithKline· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Head and neck cancer1 recruiting
• Multiple myeloma1 recruiting